VMD: Explanation of the differences in profit after tax in the first six months of 2026
Filed with HOSE · · 2 pages · English
Summary by 6ix AI
The filing details significant increases in both separate and consolidated profit after tax figures, attributing these changes to revenue growth and decreased expenses. The company emphasizes its commitment to providing accurate financial information in accordance with regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/vmd-explanation-of-the-differences-in-profit-after-tax-in-the-first-six-months-of-2026
Vimedimex Medi-Pharma JSC on 6ix
Earlier from Vimedimex Medi-Pharma JSC
- VMD: Changing from warning to supervision status
- VMD: Change in personnel
- VMD: Information on Authorization for information disclosure
- VMD: Notice of personnel change
- VMD: Approval of the selection of the auditing firm for 2026
Later from Vimedimex Medi-Pharma JSC
- VMD: Reminder of information disclosure
- VMD: Report on the progress of the remediation of the status of controlled securities
- VMD: Announcement of the status of VMD shares
- VMD: Decision on changing from supervision to trading restriction status
- VMD: Report on Corporate Governance for the first half of 2026
Follow Vimedimex Medi-Pharma JSC into a list and get an email when it puts out news.
Follow Vimedimex Medi-Pharma JSC